Last reviewed · How we verify
AK0901 capsule
At a glance
| Generic name | AK0901 capsule |
|---|---|
| Also known as | AZSTARYS (SDX/d-MPH capsules) |
| Sponsor | Shanghai Ark Biopharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AK0901 capsule CI brief — competitive landscape report
- AK0901 capsule updates RSS · CI watch RSS
- Shanghai Ark Biopharmaceutical Co., Ltd. portfolio CI